Weigh Antithrombotic Risks and Benefits for Atrial Fib Patients With CAD
November 2016
Updated Canadian guidelines will help clarify which antithrombotics to use in patients with both atrial fib and coronary artery disease.
Up to 30% of patients with atrial fibrillation (AF) also have coronary artery disease (CAD)...making management tricky.
An oral anticoagulant (warfarin, etc) is usually preferred for AF to prevent stroke...but an antiplatelet (ASA, etc) is preferred for CAD to prevent coronary events. And using both increases bleeding risk.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive